CVS Health operates as a diversified healthcare company, providing a range of services including pharmacy benefit management, retail pharmacy, and health insurance. Its core products encompass prescription medications, health services, and various health plans. Major business segments include Retail/LTC, Health Care Benefits, and Pharmacy Services, with primary revenue sources stemming from pharmacy sales, health insurance premiums, and service fees.
The investment profile of CVS Health is more aligned with balanced investors, given its combination of growth potential and dividend yield. The company offers a moderate dividend, appealing to income-focused investors, while also showing potential for capital appreciation. The stock may suit those looking for a stable investment with a mix of growth and income.
| Data | Antes | Depois | Motivo |
|---|---|---|---|
| 2026-06-05 02:35 | Manter | Comprar | Positive momentum, but revenue decline raises concerns. |
| 2026-05-20 02:40 | Comprar | Manter | Mixed performance; cautious outlook amid fundamental weakness. |
| 2026-05-08 15:02 | — | Comprar | Strong momentum and solid dividend yield support growth. |
| Data | Analista | Action | Alvo | Preço na época |
|---|---|---|---|---|
| 2026-06-08 11:26 | Mizuho Securities | Preço-alvo elevado | 110 → 115 | 95.93 |
| 2026-06-04 11:50 | Morgan Stanley | Preço-alvo elevado | 106 → 111 | 91.37 |
| 2026-06-01 11:26 | Truist Financial | Preço-alvo elevado | 102 → 108 | 90.98 |
